DRIO · DarioHealth Corp
United States · RS rating 10 · As of 2026-10-14
| Price | 5.45 USD |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 12 / 20 / 10 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 17 / 48 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +168.0% |
| Sales growth Q/Q | +4.5% |
| Distance from 52-week high | +66.3% |
| Market cap (USD) | $52.6M |